Characteristics Group A (Levocetirizine 5 mg) Group B (Desloratidine 5 mg)
No. of patients 27 27
Age in years (Mean ± SD) 35.96 ± 14.31 32.33 ± 11.49
Male/ Female 13 (48.15%)/14 (51.85%) 10 (37.04%)/17 (62.96%)
TNSS 7.37 ± 0.93 7.11 ± 1.16
RQLQ score 4.17 ± 0.5 ± 0.63
Table 1: Demographic and clinical characteristics of the two treatment groups at baseline visit.